Back to Neuberger Berman Group LLC Neuberger Berman Group LLC

ENLVENLV
6 quarters

Position history for Neuberger Berman Group LLCNeuberger Berman Group LLC's holdings in ENLIVEX THERAPEUTICS LTD

No. Neuberger Berman exited its ENLV (Enlivex Therapeutics) position in Q2 2026. Its Q1 2026 13F listed 10,988 shares worth $10,220. Neuberger Berman first reported ENLV in Q1 2025 and held it in 5 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$13,583

Total Shares Change

-14,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$131.98
0
2026-Q1
Unchanged
10,988
0.0%
$10,2200.0%$223.22
0
2025-Q4
Unchanged
10,988
0.0%
$7,7270.0%$168.77
0
2025-Q3
Unchanged
10,988
0.0%
$11,4280.0%$249.60
0
2025-Q2
Decreased
10,988
-21.5%
$12,3070.0%$268.80
0
2025-Q1
New
14,000
-
$13,5830.0%$232.85
27

Other major holders of ENLV: ARK Investment Management LLC, RENAISSANCE TECHNOLOGIES LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used